cdr3.alpha	v.alpha	j.alpha	cdr3.beta	v.beta	d.beta	j.beta	species	mhc.a	mhc.b	mhc.class	antigen.epitope	antigen.gene	antigen.species	reference.id	submitter	method.identification	method.frequency	method.singlecell	method.sequencing	method.verification	meta.study.id	meta.cell.subset	meta.subset.frequency	meta.subject.cohort	meta.subject.id	meta.replica.id	meta.clone.id	meta.epitope.id	meta.tissue	meta.donor.MHC	meta.donor.MHC.method	meta.structure.id	comment
			CASSVDGTGGALGNTIYF	TRBV9		TRBJ1-3	HomoSapiens	HLA-A*02:01	B2M	MHCI	YILEETSVM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw12			1/22 - frequency in verification, see the article for details
			CSVEXSPPGEEWWLTLRF	TRBV29-1		TRBJ1-6	HomoSapiens	HLA-A*02:01	B2M	MHCI	YILEETSVM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw13			1/22 - frequency in verification, see the article for details, see the article for details
			CAWSWGDSTNSPLHF			TRBJ1-6	HomoSapiens	HLA-A*02:01	B2M	MHCI	YILEETSVM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	19/75		sanger	antigen-loaded-targets		CD8+	25.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw14			V-segment in the article - V?210S1, IMGT analogue is not identified, 19/22 - frequency in verification, see the article for details
			CASSLVGGTGSVSYQFF	TRBV11-2		TRBJ2-1	HomoSapiens	HLA-A*02:01	B2M	MHCI	YILEETSVM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw15			1/22 - frequency in verification, see the article for details
			CASSLLMATNEKLFF	TRBV28		TRBJ1-4	HomoSapiens	HLA-B*18	B2M	MHCI	ELKRKMIYM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw16			1/26 - frequency in verification, see the article for details
			CASSYRANYEQYF	TRBV7-9		TRBJ2-7	HomoSapiens	HLA-B*18	B2M	MHCI	ELKRKMIYM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	2/75		sanger	antigen-loaded-targets		CD8+	2.67% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw17			2/26 - frequency in verification, see the article for details
			CASSQAVASGGGRSEQFF	TRBV3-2		TRBJ2-1	HomoSapiens	HLA-B*18	B2M	MHCI	ELKRKMIYM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw18			1/26 - frequency in verification, see the article for details
			CASVTGSTDTQYF	TRBV2		TRBJ2-3	HomoSapiens	HLA-B*18	B2M	MHCI	ELKRKMIYM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	7/75		sanger	antigen-loaded-targets		CD8+	9.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw19			7/26 - frequency in verification, see the article for details
			CASSDGTAYEQYF	TRBV2		TRBJ2-7	HomoSapiens	HLA-B*18	B2M	MHCI	ELKRKMIYM	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	10/75		sanger	antigen-loaded-targets		CD8+	13.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw20			10/26 - frequency in verification, see the article for details
			CASSLARNQPQHF	TRBV4-1		TRBJ1-5	HomoSapiens	HLA-B*18	B2M	MHCI	CVETMCNEY	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw21			1/26 - frequency in verification, see the article for details
			CASGGADMKTEAFF	TRBV19		TRBJ1-1	HomoSapiens	HLA-B*18	B2M	MHCI	CVETMCNEY	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw22			1/26 - frequency in verification, see the article for details
			CSANPDWGLQLWLHLRF	TRBV20-1		TRBJ2-1	HomoSapiens	HLA-B*18	B2M	MHCI	DEEDAIAAY	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw23			1/26 - frequency in verification, see the article for details
			CASSPGGGKETQYF	TRBV7-6		TRBJ2-5	HomoSapiens	HLA-B*18	B2M	MHCI	DEEDAIAAY	IE1	CMV	PMID:10756006	Anastasiia Sycheva	antigen-expressing-targets, cultivation after limiting dilution	1/75		sanger	antigen-loaded-targets		CD8+	1.33% of T-cell clones generated from donor C	HCMV-seropositive healthy donor	donor C				PBMC	HLA class I haplotypes: A2 A25 B18 B44 Cw5 Cw24			1/26 - frequency in verification, see the article for details